Clearmind Medicine Inc (CMND.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 10/31
(Values in thousands)
| 07-2025 | 04-2025 | 01-2025 | 10-2024 | 07-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 3,495 | 4,473 | 5,781 | 6,574 | 7,680 |
| Marketable Securities | 1 | 178 | 135 | 289 | 0 |
| Receivables | 211 | 181 | 210 | 181 | 191 |
| TOTAL | $3,822 | $5,023 | $6,415 | $7,088 | $7,995 |
| Non-Current Assets | |||||
| PPE Net | 27 | 34 | 44 | 52 | 60 |
| Intangibles | 100 | 103 | 106 | 108 | 111 |
| Other Non-Current Assets | 21 | 21 | 20 | 7 | 7 |
| TOTAL | $147 | $158 | $170 | $167 | $179 |
| Total Assets | $3,970 | $5,180 | $6,585 | $7,255 | $8,173 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 647 | 475 | 654 | 526 | 277 |
| Other current liabilities | 2,179 | 2,318 | 2,983 | 3,520 | 4,314 |
| TOTAL | $2,904 | $2,879 | $3,724 | $4,131 | $4,675 |
| Non-Current Liabilities | |||||
| TOTAL | $0 | $0 | $7 | $16 | $26 |
| Total Liabilities | $2,904 | $2,879 | $3,731 | $4,148 | $4,700 |
| Shareholders' Equity | |||||
| Common Shares | 25,570 | 25,338 | 24,759 | 24,168 | 23,801 |
| Retained earnings | -27,192 | -25,878 | -25,094 | -24,023 | -23,138 |
| Other shareholders' equity | 2,687 | 2,841 | 3,189 | 2,962 | 2,810 |
| TOTAL | $1,066 | $2,301 | $2,854 | $3,108 | $3,473 |
| Total Liabilities And Equity | $3,970 | $5,180 | $6,585 | $7,255 | $8,173 |